On November 1, 2017, a PathConnect software update will take place that will further restrict entry of any non-covered ICD-10 diagnosis codes for Medicare patients.
For more information, CLICK HERE
Search Results for
UPDATE: 2018 ICD-10 Updates: Z36 and Z3A
As a reminder, effective October 1, 2017, the 2018 ICD-10-CM updates are in effect (October 1, 2017 through September 30, 2018). Providers should be coding to the highest level of specificity per the 2018 ICD-10-CM updates. If an ICD code is entered that has been updated and/or now requires more specificity, suggestions for a more specific code will be displayed in PathConnect at the time of ordering as shown below.
For more information, CLICK HERE
New Prior Authorization Requirement for UnitedHealthcare
As a valued PathGroup partner, we wanted to inform you that starting November 1, 2017, notification/prior authorization will be required for certain genetic and molecular lab tests for certain UnitedHealthcare Commercial benefit plans. Ordering providers will now need to complete the prior authorization process online at the UnitedHealthcare Link Portal or over the phone.
PathGroup will be unable to complete the notification/prior authorization process for our healthcare providers. This new requirement impacts not only PathGroup, but all laboratories offering genetic and molecular based tests.
For more information,CLICK HERE
2018 ICD-10 Updates
As a reminder, effective October 1, 2017, the 2018 ICD-10-CM updates are in effect (October 1, 2017 through September 30, 2018). Providers should be coding to the highest level of specificity per the 2018 ICD-10-CM updates. If an ICD code is entered that has been updated and/or now requires more specificity, suggestions for a more specific code will be displayed as shown below.
For More Information, CLICK HERE
TEST UPDATE: Cystic Fibrosis Carrier Screening New Test Offering
Effective today, October 17, 2017, PathGroup offers a new test for Cystic Fibrosis (CF) Carrier Screening. In our effort to provide the most innovative and clinically applicable tests available, this new test includes 175 clinically relevant CFTR mutations, which improves the CFTR mutation detection rate across all ethnicities, particularly African Americans and Hispanic Americans. Professional medical organizations, including ACOG, recommend CF carrier screening be offered to all patients.1
For More Information, CLICK HERE
Pranil K. Chandra, DO to Present at 9th Annual Personalized & Precision Medicine Conference
Brentwood, TN – (Thursday, October 12, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that that Dr. Pranil K. Chandra will present at the 9th Annual Personalized and Precision Medicine Conference held October 16 – 17, 2017 in Orlando, Florida. Dr. Chandra currently serves as Vice President and Chief Medical Officer of Genomic and Clinical Pathology.
To see the full release, please CLICK HERE
Sandeep Mukherjee, Ph.D., to Present at Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting
Brentwood, TN – (Thursday, August 10, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that that Dr. Sandeep Mukherjee will present a poster abstract entitled “Prevalence of Mycoplasma genitalium in a Screening Population” at the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG) Annual Meeting held August 10-12, 2017 in Park City, Utah.
To see the full release, please click HERE
Lennon, Chandra and Olds to Present at Cancer Genomics Consortium 2017 Summer Meeting
Brentwood, TN – (Monday, August 7, 2017) – PathGroup is pleased to announce that Alan Lennon, Ph.D., FACMG, is serving as the current President-Elect for the Cancer Genomics Consortium. He is also serving as the 2017 Scientific Committee Chair for the 2017 Summer Meeting held August 7- 9, 2017 in Denver, Colorado. Dr. Lennon currently serves as the Senior Scientific Director, Clinical Cytogenetics, FISH and Microarray Services for PathGroup.
To see the full release, please click HERE
Pranil K. Chandra, DO to Serve on Association for Molecular Pathology (AMP) Solid Tumors Practice Committee
Brentwood, TN – (Thursday, August 3, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that that Dr. Pranil K. Chandra has been selected to serve a two-year term on the Solid Tumors Clinical Practice Committee for the Association for Molecular Pathology (AMP).
To read the full release, please click HERE
Adam E. Meyer, MD to Serve as Associate Medical Director of Clinical Pathology Services
Brentwood, TN – (Thursday, July 27, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that that Dr. Adam E. Meyer has joined the PathGroup team as the Associate Medical Director of Clinical Pathology Services.
Click HERE to see the full release